‘‘SEC. 918. RESEARCH PROGRAM TO IMPROVE DIAGNOSTIC 
SAFETY AND QUALITY. 
‘‘(a) IN GENERAL.—The Director shall establish a 
comprehensive program of research and quality improve-
ment to— 
‘‘(1) assess and understand diagnostic errors, 
including diagnostic delays, and how to eliminate 
common failures in the diagnostic process that lead 
to significant patient harm; and 
‘‘(2) identify, develop, implement, and dissemi-
nate evidence-based strategies and best practices for 
improving diagnostic quality, safety, and health care 
value. 
‘‘(b) ACTIVITIES.—The program established under 
subsection (a) shall include the following: 
‘‘(1) CONTINUUM OF RESEARCH.—A portfolio 
of conducted and supported activities that is con-
sistent with the general, research, implementation, 
and dissemination activities of the Center for Qual-
ity Improvement and Patient Safety, as described in 
section 933, including— 
‘‘(A) investigator-initiated research to as-
sess diagnostic errors and identify improved 
methods to prevent errors and the harm they 
cause; 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
‘‘(B) translation and synthesis of research 
findings and development of tools for imple-
menting prevention strategies into practice; 
‘‘(C) implementation research to refine evi-
dence-based tools for improving diagnostic proc-
esses and effectively integrate these solutions 
into practice; and 
‘‘(D) dissemination to promote implemen-
tation of effective methods, strategies and tools 
for wide-scale improvement. 
‘‘(2) RESEARCH CENTERS OF DIAGNOSTIC EX-
CELLENCE.—Grants or contracts awarded to public 
or private entities, in geographically diverse locations 
throughout the United States, that link research di-
rectly with clinical practice and that may include— 
‘‘(A) academic medical and institutional re-
search centers that combine demonstrated mul-
tidisciplinary expertise in diagnostic outcomes 
or quality improvement research with linkages 
directly or through national, state or local 
stakeholder partner organizations to relevant 
sites of care; and 
‘‘(B) provider-based research networks, in-
cluding plan, facility, or delivery system sites of 
care (especially primary care), that can evaluate 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
outcomes and evaluate and promote quality im-
provement approaches. 
‘‘(3) FINANCIAL
ASSISTANCE.—The Director 
may provide financial assistance to assist in meeting 
the costs of planning and establishing new centers, 
as well as operating existing and new centers, pursu-
ant to section 902(c). 
‘‘(4) STAKEHOLDER
ENGAGEMENT.—The Di-
rector shall identify and enter into a supporting 
agreement (grant or contract) with a nonprofit enti-
ty that convenes a coalition of diverse health care 
stakeholders for the purpose of— 
‘‘(A) raising attention to diagnostic safety 
and quality concerns; 
‘‘(B) facilitating learning, adoption and 
spread of effective quality improvement inter-
ventions; and 
‘‘(C) catalyzing novel actions by individual 
member organizations to reduce harms from di-
agnostic error and improve patient outcomes. 
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.— 
‘‘(1) IN GENERAL.—To carry out this section, 
there is authorized to be appropriated $20,000,000 
for fiscal year 2023, $25,000,000 for fiscal year 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
2024, $30,000,000 for fiscal year 2025, and 
$35,000,000 for each of fiscal years 2026 and 2027. 
‘‘(2) RESERVATION.—Of the amount appro-
priated under paragraph (1) for a fiscal year, 
$700,000 shall be allocated to carrying out the pur-
pose described in subsection (b)(4). 
‘‘(3) 
AVAILABILITY.—Amounts 
appropriated 
under this section shall remain available until ex-
pended.’’. 
SEC. 3. FELLOWSHIPS AND TRAINING GRANTS. 
(a) RUTH KIRCHSTEIN AWARDS.—Section 487(a) of 
the Public Health Service Act (42 U.S.C. 288(a)) is 
amended by adding at the end the following: 
‘‘(5) For purposes of the program under this sub-
section, biomedical and behavioral research includes diag-
nostic safety and quality research.’’. 
(b) AHRQ PROGRAMS.—Section 902(b)(1) of the 
Public Health Service Act (42 U.S.C. 299a(b)(1)) is 
amended— 
(1) by inserting ‘‘and diagnostic safety and 
quality’’ after ‘‘subsection (a)’’; and 
(2) by striking ‘‘under section 487(d)(3)’’ and 
inserting ‘‘for purposes of carrying out section 487’’. 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB
SEC. 4. QUALITY MEASURE DEVELOPMENT. 
Section 931(c)(2) of the Public Health Service Act 
(42 U.S.C. 299b–31(c)(2)) is amended— 
(1) 
by 
redesignating 
subparagraphs 
(B) 
through (J) as subparagraphs (C) through (K), re-
spectively; and 
(2) by inserting after subparagraph (A) the fol-
lowing: 
‘‘(B) diagnostic safety and quality;’’. 
SEC. 5. DATA FOR RESEARCH AND IMPROVEMENT. 
Section 937(f) of the Public Health Service Act (42 
U.S.C. 299b–37(f)) is amended— 
(1) by striking ‘‘The Secretary’’ and inserting 
the following: 
‘‘(1) IN GENERAL.—The Secretary’’; and 
(2) adding at the end the following: 
‘‘(2) CONSULTATION WITH EXPERT PANEL.—In 
carrying out paragraph (1), the Secretary, in coordi-
nation with the Director, the Administrator of the 
Centers for Medicare & Medicaid Services, the Na-
tional Coordinator for Health Information Tech-
nology, and the Director of the National Library of 
Medicine, shall convene an expert panel to consider 
and make recommendations regarding the types, 
sources, and availability of data needed to accelerate 
diagnostic safety and quality research, training, and 
VerDate Sep 11 2014 
16:30 Jul 03, 2022
Jkt 029200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H8172.IH
H8172
pbinns on DSKJLVW7X2PROD with $$_JOB